Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell

<div>Immunohistochemical staining of RAC2 in different subtypes of BRCA. RAC2 was significantly highly expressed in luminal A, luminal B, Her-2 positive, and triple-negative types.</div>

Stem Cells International

fig14

Figure 14

Figure 14: Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell 